PENGEMBANGAN TES DIAGNOSTIK BERBASIS REAL-TIME PCR UNTUK DETEKSI VIRUS HEPATITIS B (HBV) DI INDONESIA
Based on a serological test, the prevalence of hepatitis B in Indonesia is 7.1 % and categorizes Indonesia as a country with moderate endemicity of hepatitis B. The treatment of hepatitis B aims to suppress the replication of viral particles, and a diagnostic test based on real-time PCR is requir...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/48535 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Based on a serological test, the prevalence of hepatitis B in Indonesia is 7.1 % and
categorizes Indonesia as a country with moderate endemicity of hepatitis B. The treatment of
hepatitis B aims to suppress the replication of viral particles, and a diagnostic test based on real-time
PCR is required to monitor the development of the treatment. But to date, there is no real-time PCR
for HBV diagnostic test produced by Indonesia. Therefore, the goal of this research is to develop
real-time PCR for HBV diagnostic test. A in silico study is conducted to determine the target gene
through multiple sequence alignment. The primer is designed with SnapGeneTM software to create
the desirable characteristics of primer, which is 15-30 bp in size, having 30-80% of GC Content, and
Tm above 55oC. The control positive is also designed by inserting target sequence into the backbone
of plasmid pUC57. The amplification performance of the primer is tested by real-time PCR. To get
the best result of amplification performance, and the profile of an amplicon, the primer concentration
used is the combination without dimer primer artifact. This combination is determined by conducting
an experiment of real-time PCR without template and varies the primer concentration in range 100
to 300 nM. The target sequence is within the S region of the HBV genome, which is the 183rd to
269th nucleotide. The primer has good character and conserved in 60 sequences of HBV genome
from different strain. From this study, there are four primer combination to minimize the formation
of primer dimer artifact and lower the efficiency of amplification, those are 100-300 nM for forward
primer, and 200 nM for reverse primer; 100 nM for forward primer and 300 nM for reverse primer.
Real-time PCR results showed that the primer has succeeded to amplify a sequence which has
melting temperature close to in silico prediction, 80oC. In conclusion, primer designed in this study
could be a candidate for real-time PCR for HBV diagnostic test in Indonesia. |
---|